Our findings thus provided novel insights into the role of rutin in anti-pancreatic tumor treatment via the rutin-miR-877-3p-Bcl-2 axis and a promising therapeutic strategy for PC. This evidence concerns the gene BCL2 and pancreatic neoplasm.